KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Net Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 561.00
Dec 31, 2025 9,982.00
Sep 30, 2025 82.00
Jun 30, 2025 1,214.00
Mar 31, 2025 2,970.00
Dec 31, 2024 1,522.00
Sep 30, 2024 -1,125.00
Jun 30, 2024 -795.00
Mar 31, 2024 -12,766.00
Dec 31, 2023 -291.00
Sep 30, 2023 -1,403.00
Jun 30, 2023 1,358.00
Mar 31, 2023 -662.00
Dec 31, 2022 6,244.00
Sep 30, 2022 54.00
Jun 30, 2022 -353.00
Mar 31, 2022 -1,753.00
Dec 31, 2021 591.00
Sep 30, 2021 -853.00
Jun 30, 2021 -1,260.00
Mar 31, 2021 -600.00
Dec 31, 2020 -8,307.00
Sep 30, 2020 396.00
Jun 30, 2020 524.00
Mar 31, 2020 -3,385.00
Dec 31, 2019 -1,216.00
Sep 30, 2019 379.00
Jun 30, 2019 1,406.00
Mar 31, 2019 426.00
Dec 31, 2018 308.00
Sep 30, 2018 1,435.00
Jun 30, 2018 -812.00
Mar 31, 2018 1,139.00
Dec 31, 2017 -6,638.00
Sep 30, 2017 3,288.00
Jun 30, 2017 -907.00
Mar 31, 2017 32.00
Dec 31, 2016 -1,032.00
Sep 30, 2016 -408.00
Jun 30, 2016 -295.00
Mar 31, 2016 -357.00
Dec 31, 2015 1,778.00
Sep 30, 2015 -1,396.00
Jun 30, 2015 -2,606.00
Mar 31, 2015 323.00
Dec 31, 2014 -14,580.00
Sep 30, 2014 1,529.00
Jun 30, 2014 -1,151.00
Mar 31, 2014 2,302.00